drugset / Trial / NCT00700518

Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon

NCT00700518

Phase 1 Completed 10 enrolled Procris Pharmaceuticals
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the blood flow response to topical Glyceryl Trinitrate when applied to the skin of patient's fingers with Raynaud's Phenomenon.

Timeline

Start
2008-06
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitroglycerin Unknown 0.6 mg Topical
Comparator Nitroglycerin Unknown 1.2 mg Topical
Comparator Nitroglycerin Unknown 1.8 mg Topical
Comparator Nitroglycerin Unknown 2.4 mg Topical

Indications